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Mostneurons in the adultmammalianbrain survive for
the entire life of an individual. However, it is not known
which transcriptional pathways regulate this survival
in a healthy brain. Here, we identify a pathway regu-
lating neuronal survival in a highly subtype-specific
manner. We show that the transcription factor Pax6
expressed in dopaminergic neurons of the olfactory
bulb regulates the survival of these neurons by
directly controlling the expression of crystallin aA
(CryaA), which blocks apoptosis by inhibition of
procaspase-3 activation. Re-expression of CryaA
fully rescues survival of Pax6-deficient dopaminergic
interneurons in vivo and knockdown of CryaA by
shRNA inwild-typemice reduces thenumberofdopa-
minergic OB interneurons. Strikingly, Pax6 utilizes
different DNA-binding domains for its well-known
role in fate specification and this role of regulating
the survival of specific neuronal subtypes in the
mature, healthy brain.
INTRODUCTION
Despite their well characterized role in development, functions of
homeobox transcription factors in the adult brain still remain
elusive. For example, members of the paired-type homeobox
(Pax) transcription factor family are expressed in specific
neurons in the midbrain and the olfactory bulb (Stoykova and
Gruss, 1994), but neither their targets nor the physiological role
of this late expression is known. As almost all Pax transcription
factors act as fate determinants during development (Osumi
et al., 2008), it is possible that they function similarly in adulthood
to maintain neuronal identity. Alternatively, Pax transcription
factors expressed in mature neurons may regulate novel targets
important for specification or regulation of neuronal function and682 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.activity. Finally, it is conceivable that Pax transcription factors
regulate pathways involved in neuronal survival. Indeed, it is
puzzling that specific types of neurons succumb to neurodegen-
eration, despite the rather widespread expression of the genes
affected by the disease-causing mutations (Alavian et al.,
2008; Friedlander, 2003; Zhao et al., 2008). Thus, neuronal
subtype-specific expression of regulatory transcription factors
may contribute to selective cell death.
Here, we examined the role of Pax6 in mature dopaminergic
neurons of the olfactory bulb (OB) in mice. Pax6 is expressed in
stem and progenitor cells in some regions of the developing
CNS during neurogenesis (Ericson et al., 1997; Heins et al.,
2002; Kohwi et al., 2005; Stoykova and Gruss, 1994; Stoykova
et al., 2000) but only in very few neuronal subpopulations in the
adult brain, such as the dopaminergic neurons in the glomerular
layer of the OB, granule neurons in the cerebellum, and amacrine
and ganglion cells of the retina (Stoykova andGruss, 1994). Pax6
expression in progenitors ceases at early postnatal stages and
persists only in progenitors in the adult neurogenic regions (Brill
et al., 2009; Hack et al., 2005; Kohwi et al., 2005; Stoykova and
Gruss, 1994). Pax6actsproneurogenic inadult neural progenitors
(Hack et al., 2005), similar to its role during development (Heins
et al., 2002), but also plays a role to specify neuronal subtype
identity in the adult anddevelopingbrain (Hack et al., 2005; Kohwi
et al., 2005; Kroll and O’Leary, 2005; Nikoletopoulou et al., 2007;
Stoykova et al., 2000; Tuoc et al., 2009). Pax6 cooperates with
Dlx2 in adult neuroblasts to specify the dopaminergic identity of
periglomerular neurons (PGNs) in the olfactory bulb (Brill et al.,
2008; Hack et al., 2005). As only these dopaminergic neurons
continue to express Pax6 lifelong, it is also conceivable that
Pax6 may be further required to maintain this neuronal subtype
identity. Interestingly, the dopamine levels are subject to activity
dependant regulation in PGNs (Bastien-Dionne et al., 2010).
Here, we used genetic ablation of Pax6 exclusively in mature
dopaminergic neurons and found that Pax6 is essential to inhibit
programmed cell death of these neurons by controlling the
expression of CryaA which prevents activation of procaspase-
3. These data reveal a pathway of transcriptional regulation of
Figure 1. Pax6 Function Is Necessary for
the Survival of Dopaminergic Periglomeru-
lar Neurons
(A and B) Schematic representation of the main
neuronal layers in the OB (A) and neuronal
subtypes in the GL (B, region depicted as white
square in A).
(C)Fluorescencemicrographdepicting that virtually
all TH-immunoreactive dopaminergic periglomeru-
lar neurons (red) also contain Pax6 (green) in
3-month-old mice.
(D–F) Loss of Pax6 in homozygous Pax6fl/fl mice
after DAT::Cre mediated recombination and indi-
cated by GFP reporter (green) results in reduced
reporter+ (D, E0, F0) and TH+ (red) (D, E00, F00) cells
(11 animals for control and 7 for Pax6fl/fl). (E and F)
Fluorescence micrographs depicting the GL (out-
lined with dotted lines) of Pax6 deficient animals
(F) and heterozygote siblings (E) immunostained
for TH (red) and GFP reporter (green). Note the
reduced number of cells positive for the GFP
reporter (indicating Pax6-deficient cells) and for
TH in Pax6fl/fl animal (arrows in (F).
Abbreviations: GL, glomerular layer; EPL, external
plexiform layer; ML, mitral cells; GCL, granular cell
layer; RMS, rostral migratory stream; IPL, internal
plexiform layer; Gm, glomerulus; TH, tyrosine
hydroxylase; CR, calretinin; CB, calbindin. Scale
bars: 50 mm. ***p < 0.001 and brackets in (D) repre-
sent SEM. See also Figure S1.
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The Role of Pax6 and CryaA in Postmitotic Neuronsneuronal survival in a highly subtype-specific manner in the
adult brain.RESULTS
Pax6 Is Necessary for Survival of Dopaminergic PGNs
Periglomerular neurons (PGNs) represent a heterogeneous popu-
lationof bothexcitatory and inhibitory interneurons in the olfactory
bulb (Figures 1A and 1B; Brill et al., 2009; Kosaka et al., 1988;
Kosaka and Kosaka, 2007; Nakamura et al., 2005). A subpopula-
tion of about 20% of the inhibitory PGNs employs the transmitter
dopamineandexpresses the transcription factorPax6 (Figure1C).
Consistent with previous data (Hack et al., 2005), we found thatNeuron 68, 682–694, Nvirtually all dopaminergic PGNs identified
as immunoreactive to thedopamine trans-
porter (DAT), which is expressed only in
fully mature dopaminergic neurons
several weeks after their birth (Revay
et al., 1996), are also Pax6 immunoreac-
tive (91% ± 3%, n[animals] = 11, at least
1000 cells per animal analyzed). Similarly
neurons expressing tyrosine hydroxylase
(TH), the rate-limiting enzyme for dopa-
mine biosynthesis, in the glomerular layer
are positive for Pax6 (Figure 1C).
To address the function of Pax6 in
these fully mature postmitotic neurons
we genetically ablated Pax6 by Cre-Loxrecombination in mice with Cre expressed from the DAT locus
(DAT::Cre [Zhuang et al., 2005]) and exons 4–6 of the Pax6
gene flanked by loxP sites (Pax6fl/fl) (Ashery-Padan et al.,
2000). Since Pax6 is not expressed in any other dopaminergic
neuron population in the brain (Stoykova and Gruss, 1994), this
allowed us to specifically examine the role of Pax6 in dopami-
nergic OB interneurons. Recombination mediated by DAT::Cre
and indicated by a GFP reporter (Novak et al., 2000) was specific
to mature DAT-expressing neurons (no DAT-negative cells were
recombined and GFP+ [see Figures S1A and S1B available
online]) and efficient (70% ± 6% of all DAT+ PGNs were GFP+;
5 animals; 450 cells analyzed per animal; Figures S1A and
S1B). Notably, however, we also observed a small fraction of
calretinin+ PGNs expressing DAT and hence also beingovember 18, 2010 ª2010 Elsevier Inc. 683
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The Role of Pax6 and CryaA in Postmitotic Neuronsrecombined by DAT::Cre (Figure S1F), while no overlap was
found with calbindin+ PGNs (Figure S1H).
We were surprised to see that Cre+ cells in 2-month-old DAT::
Cre//Pax6fl/fl mice were still Pax6 immunoreactive (Figure S1E).
To examine whether this is due to a failure to recombine the
Pax6 floxed alleles or to stability of the Pax6 protein, we exam-
ined Pax6 mRNA in the GFP+ PGNs isolated by FACS. We
observed that Pax6 mRNA levels were severely decreased in
GFP+ PGNs of DAT::Cre//Pax6fl/fl mice to 10% ± 3% of its level
in their DAT::Cre//Pax6fl/+ siblings, while Pax6 protein levels
were not yet reduced, suggesting a high stability of Pax6 protein
in postmitotic neurons. When we examined DAT::Cre// Pax6fl/fl
mice at 3.5 months of age, virtually all Cre+ PGNs had lost
Pax6 protein (Figures S1C, S1D, and S1E).
After Pax6 had disappeared, we noted a profound reduction in
GFP+ and TH+ or DAT+ neuron numbers in the OB (Figures 1D–
1F). This decrease in the number of dopaminergic PGNs may
result from a fate conversion upon loss of Pax6, as Pax6 acts
as a fate determinant of the dopaminergic PGN subtype
throughout adulthood (Brill et al., 2008; Hack et al., 2005).
However, we saw neither an increase in any other neuronal
subtypes (calretinin+ or calbindin+) in the GL of DAT::Cre//
GFP//Pax6fl/fl mice in comparison to their WT siblings (Figures
1D and S1F–S1I), nor reporter positive cells immunoreactive
for typical glial markers such as GFAP, S100b, O4, or GST-p
(data not shown) in the OBs of DAT::Cre//GFP//Pax6fl/fl. More-
over, no other abnormalities were detectable in the OBs of
DAT::Cre//GFP//Pax6fl/fl mice (Figures S1J–S1P), suggesting
that neither fate conversion nor non-cell-autonomous effects
took place after Pax6 deletion in dopaminergic PGNs. Instead,
we observed a significant decrease in the number of GFP
reporter+ cells in the OBs of DAT::Cre//GFP//Pax6fl/fl compared
to heterozygous or WT littermate mice (Figure 1D), suggesting
that the dopaminergic neuronsmay succumb to cell death rather
than acquire a different fate. This loss of dopaminergic PGNs
was not due to unspecific effects of expressing high levels of
Cre or GFP in dopaminergic neurons, as DAT::Cre//GFP+
neurons did not die in the OB of heterozygous floxed mice nor
in themidbrain where Pax6 is not expressed in the dopaminergic
neurons (data not shown). Therefore, these data suggest that
loss of Pax6 affects specifically the survival of mature dopami-
nergic PGNs.
To elucidate the mechanism by which Pax6-deficient neurons
die, we stained dissociated cells of the adult OB for propidium
iodide (PI) and annexinV (Casciola-Rosen et al., 1996) to discrim-
inate live (annexinV-negative, PI-negative), early apoptotic
(annexinV-positive, PI-negative) and necrotic/late apoptotic (an-
nexinV-positive, PI-positive) cells (Figures 2A and 2B). Reporter-
positive (Figure 2C), Pax6fl/fl cells from the OB of 3.5 month old
mice contained significantly (p < 0.01) more early apoptotic cells
(21.1% ± 1.5%; 3 animals, 10,000 events per animal) than cells
from the OB of their heterozygous siblings (13.2% ± 1.0%; 3
animals, 10000 events per animal) (Figures 2D and 2E) that did
not differ fromWT animals (data not shown). Among adult gener-
ated neuroblasts that newly arrive in theOB, about 50%succumb
to cell death and the remainder incorporate into the neuronal
network (Petreanu and Alvarez-Buylla, 2002). Several thousand
new neurons, including dopaminergic neurons, arrive per day in684 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.the OB (Lois and Alvarez-Buylla, 1994), which explains the high
proportion of cells in the early apoptotic phase among GFP+ cells
in the OB of WT and heterozygous Pax6fl/+ mice. Also, there was
no difference in annexinV-positive nonrecombined reporter
negative cells (data not shown), supporting the specificity and
cell-autonomous nature of apoptosis induced in dopaminergic
OB neurons upon loss of Pax6. To further assay for apoptotic
death of dopaminergic PGNs in these mice we performed
activated caspase-3 immunostaining. We observed a significant
3-fold increase (p < 0.05) in the number of activated caspase-3
immunoreactive cells among the Pax6-deficient dopaminergic
neurons at 3months of age (Figure 2F), the timewhenPax6 immu-
noreactivity is lost in the OB dopaminergic neurons (Figure S1E).
Loss of CryaA Expression Causes Neuronal Death upon
Pax6 Depletion
To further elucidate the role of Pax6 in preventing programmed
cell death (PCD) in dopaminergic PGNs, we examined the path-
ways that commit dopaminergic PGNs to the PCD in the absence
of Pax6 function. p75 and galectin have been implicated in
regulatingneuronal cell death (Nikoletopoulouetal., 2007;Plachta
et al., 2007), including the death of misspecified neurons in the
embryonic cortex andmidbrain (Alavian et al., 2009; Nikoletopou-
lou et al., 2007; Plachta et al., 2007). We examined p75 and
galectin in the adult OB upon loss of Pax6. The number of cells
immunoreactive for p75 and galectin (Figures S2A–S2C and
data not shown) and the mRNA expression levels of p75
(Figure S2D) among the reporter positive cells isolated by FACS
did not differ between the genotypes. As this analysis was carried
out at the stage when the annexinV+ fraction of dopaminergic OB
neurons was increased (3.5-month-old mice; Figures 2D and 2E),
we concluded that p75 and galectin are not altered and not
responsible for the death of dopaminergic PGNs devoid of Pax6.
Next, we examined the crystallin gene family (Lanneau et al.,
2008) since its members are well-known targets of Pax6 in the
lens (Cvekl and Duncan, 2007) and also regulate cell survival
(Morozov and Wawrousek, 2006). Among the crystallins, aB-
and bB2-crystallin have been reported to be expressed in the
brain (Graw,2009).However, in neuronsof theOB includingdopa-
minergic PGNs, we surprisingly detected crystallin aA (CryaA),
which had not yet been reported to be expressed in the brain
(Graw, 2009; Figures 3A, 3B, andS3). Interestingly,CryaAexpres-
sion was confined to the mature neurons immunoreactive to the
panneuronal marker NeuN (Figures S3C–S3E). While 97% of
DAT::Cre+ cells were CryaA+ in WT and heterozygous Pax6fl/+
mice (704 cells counted, 6 animals), only 20% (820 cells counted,
9 animals) were double positive in Pax6fl/fl mice at 3.5 months of
age (Figures 3B and 3C), demonstrating a specific loss of CryaA
in the Pax6-deficient neurons. These data raised the possibility
that the reduced levels of CryaA may be causative for the death
of dopaminergic PGNs after loss of Pax6.
To test this hypothesis, we transduced adult neuronal progen-
itors in theRMSof 2.5-month-oldmicewith lentiviruses encoding
for CryaA-specific shRNA 5 (Figures 3E, S4A, and S4B) or for
a control shRNA (Figure 3D). Both virus constructs expressed
GFP from an independent promoter to identify transduced cells.
As CryaA shRNA 5 efficiently knocks down CryaA (Figures S4A
and S4B), we depleted CryaA from all adult-generated OB
Figure 2. Propidium Iodide (PI)/AnnexinV-Based Cell Death Analysis of OB Cells after DAT::Cre-Mediated Pax6 Deletion
This method is based on the difference in integrity of the plasma membrane in apoptosis and necrosis. One of the earliest features of apoptotic cells is the
translocation of the phospholipid phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane. Therefore, early apoptotic cells can be effi-
ciently labeled with annexinV, which has a high affinity to PS. Loss of plasma membrane integrity, characterizing both necrosis and the late phase of apoptosis,
allows passage of propidium iodide (PI) through the plasmamembrane and labeling of DNA. Assessing recombined, reporter positive cells (P2) population in (C) in
the DAT::Cre//GFP//Pax6fl/fl (E) and DAT::Cre//GFP//Pax6fl/+ control animals (D) for PI and annexinV, allowed us to distinguish between live (annexinV-negative,
PI-negative), early apoptotic (annexinV-positive, PI-negative) and necrotic/late apoptotic (annexinV-positive, PI-positive) cells (B).
(A and B) Dot blots illustrating gate definition for the GFP (A), PI, and annexinV (B) based on analysis of WT (GFP-negative) not stained cells.
(C–E) Dot blots showing the analyses of recombined cells (P2 population) in Pax6 mutant (DAT::Cre//GFP//Pax6fl/fl) (E) and its control sibling (D).
(F) Histogram depicting the proportion of recombined cells immunoreactive to activated caspase-3 before (1 month) and after (3 month) the loss of Pax6 protein
(three animals analyzed per genotype, per time point and at least 150 cells analyzed per animal). Data are shown as mean value ± SEM.
See also Figure S2.
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not changed 8weeks after viral vector injection, andwe could not
observe any differences in the distribution ofGFP-positive cells in
the OB between control and CryaA shRNA transduced cells
(Figure 3F). However, when we analyzed the proportion of trans-
duced cells with dopaminergic identity 8 weeks after the viral
transduction, we observed a significant decrease (p < 0.005) in
DAT+ cells among transduced cells to 25% of the proportion
observed in the control shRNA transduced cells (Figure 3F).
Thus, CryaA is specifically required for the survival of dopami-
nergic, but not of all adult generated OB interneurons.
To test whether CryaA is sufficient to maintain dopaminergic
neurons even in the absence of Pax6, we examined whether
CryaA expression rescues Pax6-deficient dopaminergic PGNs
from apoptosis. We infected adult neuronal progenitorsmigrating
in the rostral migratory stream toward the OB with a MLV-based
retroviral vector encoding forCryaAanddsRedor a control vectorcontaining dsRed only (Figures 3G and 3H). Thereby we target all
adult generated neuroblasts with a permanent, Pax6-indepen-
dent expression of CryaA. To allow sufficient differentiation time
and to examine whether migration and differentiation occurs
normally despite the overexpression of CryaA, we examined the
OBs 2 months after viral vector injection into the RMS of 2.5-
month-old DAT::Cre//GFP//Pax6fl/+ or DAT::Cre//GFP//Pax6fl/fl
mice. Virus-transduced (dsRed+; white arrow in Figures 3G and
3H)cells had reached theOBanddifferentiated intodopaminergic
neurons (yellow arrow in Figure 3H). These dopaminergic neurons
also expressed DAT::Cre and were GFP+ (Figures 3D–3F). The
proportion of dopaminergic neurons labeled by GFP (in green)
among the virally transduced cells expressing dsRed (in red) in
DAT::Cre//GFP//Pax6fl/+ mice was similar to previous analyses
(Brill et al., 2008;Hack et al., 2005) anddid not differ between virus
expressing CryaA and control virus expressing only dsRed
(Figure 3I). These data indicate that overexpression of CryaANeuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc. 685
Figure 3. CryaA Is Sufficient to Rescue the
Survival of Pax6-Ablated Periglomerular
Neurons
(A and A0) Micrographs depicting CryaA mRNA
expression in the adult brain confined to the OB.
(B and C) Micrographs depicting the reduced
proportion of Cre+ (red) cells double-labeled for
CryaA (green; yellow arrows indicate double+
cells) after loss of Pax6 in DAT::Cre//GFP//Pax6fl/fl
mice (C, 20% ± 4% double+; 9 animals) compared
to the control (B, 97% ± 3% double+; 6 animals).
(D–E) Micrographs depicting dopaminergic
neuronal population in the olfactory bulb (TH,
red) after lentivirus-mediated CryaA knockdown
(E and E0) and overexpression of the control
shRNA (D and D0). Transduced cells are GFP-
immunoreactive and (D0 ) and (E0) are magnifica-
tions of boxed areas in (D) and (E), respectively.
(F) Histograms showing the distribution of CryaA
(gray bars) or control shRNA (open bars) trans-
duced cells in the OB 8 weeks after transduction
(left histogram) and the proportion of dopami-
nergic neurons (right histogram). Note significant
decrease (p < 0.005) in CryaA-deficient cells with
dopaminergic identity (2% ± 0.5% of all trans-
duced cells in the GL, 4 animals analyzed),
compared with the control shRNA transduced
cells (8% ± 2% of all transduced cells in the GL,
4 animals analyzed).
(G–J) Retrovirus-mediated CryaA expression (red
in H and I) rescues the loss of dopaminergic
PGNs (green as GFP+ by DAT::Cre//GFP; yellow
arrow) in DAT::Cre//GFP//Pax6fl/fl mice (three
animals), while control virus expressing DsRed
only (G and I) fails to rescue (three animals). (J)
Histogram depicting the annexinV-positive, dying
cells 6 weeks after the re-expression of CryaA
(GFP and dsRed) or control vector (dsRed only)
in the Pax6-depleted periglomerular neurons iden-
tified by the GFP immunoreactivity (three animals
analyzed).
Abbreviations: as in Figure 1 and Ctx, cortex; LV, lateral ventricle; SEZ, subependymal zone; OB, olfactory bulb. Scale bars: 20 mm in (B) and (C); 50 mm in (D), (E),
(G), and (H) and 100 mm in (D0 ) and (E0). ***p < 0.001 and brackets in (F) and (I) are SEM.
See also Figure S3.
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cells. Moreover, the proportion of dopaminergic GFP+ neurons is
equal between cells overexpressingCryaA and cells infectedwith
the control virus in the OB of DAT::Cre//GFP//Pax6fl/+ mice
(Figure 3I), suggesting that endogenous levels of CryaA are suffi-
cient formaximal survival. Conversely, in DAT::Cre//GFP//Pax6fl/fl
the proportion of dopaminergic GFP+ neurons among the control
dsRed+-labeled cells was reduced to less than 20% of control
levels (Figure3I)demonstrating that thesurvivalof adult generated
dopaminergic PGNs depends on the maintenance of Pax6
expression in their mature state. In pronounced contrast, the
proportion of GFP+ dopaminergic neurons among the CryaA
transduced cells was equal to the controls even in DAT::Cre//
GFP//Pax6fl/fl (Figures 3E and 3F), demonstrating that CryaA
expression is able to fully rescue the dopaminergic neurons
upon loss of Pax6protein. Notably, this rescue alsodemonstrated
that these cells do not need Pax6 expression per se to maintain
their dopaminergic identity, as deletion of Pax6 inmatureDAT-ex-686 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.pressing neurons did not alter the proportion of this neuronal
subtype when its survival was rescued by CryaA expression.
To determine whether CryaA re-expression in Pax6-deficient
dopaminergic PGNs rescues their numbers due to improved
survival, we analyzed the proportion of dying cells using the
annexinV-based assay in DAT::Cre//GFP//Pax6fl/fl animals with
or without CryaA-mediated rescue by FACS. We observed
a 2-fold decrease in the proportion of dying cells after retroviral
vector expression of CryaA compared to the control vector
(Figure 3J; cells double-positive for dsRed and GFP). Impor-
tantly, the overexpression of CryaA did not affect the survival
of nondopaminergic cells that had a similar rate of 10% cell
death in both CryaA and control virus-transduced cells
(Figure 3J; dsRed only cells) in agreement with no change in
the number of nondopaminergic cells upon retroviral expression
of CryaA (Figures 3G–3I). Taken together, CryaA does not alter
the fate and the specification of PGN but prevents PCD of
dopaminergic PGNs downstream of Pax6.
Figure 4. CryaA Knockdown Induces Apoptosis via Caspase-3 Activation
(A–C) Confocal images showing reduction in numbers of P19 cells transfected with the virus expressing GFP and CryaA-specific shRNA5 (B and B0) compared to
the controls (A, A0, C, and C0).
(D) Caspase specific inhibitor ZVAD-fmk blocks the effect of CryaA-specific shRNA5 on number and morphology of P19 cells (compare D and B).
(E) Histogram depicting the increase in the proportion of early apoptotic and late apoptotic/necrotic cells after CryaA knockdown as detected by annexinV and PI
staining and FACS analyses (3 experiments, 10,000 events per condition).
(F) Western blot depicting the activation of procaspase-3 (upper band, 30 kDa) and release of active caspase-3 form (lower bands, 13 and 17 kDa) only after the
transient transfection of P19 cells with CryaA specific shRNA5.
Abbreviations: hpt, hours after transfection; ***p < 0.001; ****p < 0.0001. Brackets in (E) are SEM. Scale bars: 50 mm in (A), (B), (C) and (D); 10 mm in (A0), (B0 ) and (C0).
See also Figure S4.
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We performed shRNA mediated knockdown of CryaA in the P19
cell line grown under both undifferentiated and differentiated
conditions (see Experimental Procedures). P19 cells express
Pax6 and CryaA in both conditions investigated (Figures S4B
and S5C) and the CryaA protein can be efficiently depleted
from these cells by CryaA-specific shRNA5 expression as
described above (Figures S4A and S4B). Supporting the idea
that a reduction of CryaA results in apoptosis, shRNA5-mediated
CryaA knockdown in P19 cells resulted in reduced numbers of
CryaA-shRNA5-transfected cells compared to the control
shRNAs (Figures 4A–4C) by 30 hr after the transfection. CryaA
shRNA5-expressing cells display cell rounding, pyknotic nuclei
and nuclear fragmentation (Figure 4 and data not shown), the
typical hallmarks of cells undergoing PCD (Boldyrev, 2000).
Significantly increased fractions of early apoptotic and late
apoptotic/ necrotic cells preceded the reduction in the number
of CryaA-shRNA5 transduced cells, as revealed by PI and
annexinV staining 24 hr after transduction (Figure 4E). As the
activation of caspase-3 is the key event in the commitment of
cells to PCD (Conradt, 2009), we examined caspase-3 protein
following CryaA knockdown. When protein extract from control
or CryaA-shRNA5 transduced P19 cells was probed with an
anti-caspase antibody recognizing both active (13 and 17 kDa)
and pro-form (39 kDa), only cells exposed to CryaA knockdownshowed activated caspase-3 (Figure 4F). Conversely, these
bands were undetectable after control transfection or in the
protein extracts of nontransfected cells (Figure 4F). Consistent
with a role of caspase-3 activation inmediating the CryaA knock-
down triggered apoptosis, treatment of CryaA shRNA5-trans-
fected cells with the caspase inhibitor ZVAD-fmk fully abolished
cell death (Figure 4D). As activation of caspase-3 has also been
implicated in cellular functions other than PCD, such as neuronal
differentiation (Chen et al., 1998), we performed time-lapse
imaging (Costa et al., 2008; Eilken et al., 2009) to further examine
the role of CryaA. Although 90% of the progeny of CryaA-
specific shRNA5 transfected cells died within 35 hr of observa-
tion (Figures S4C and S4D), CryaA knockdown did not interfere
with cell cycle length or themode of division of P19 cells grown in
undifferentiated conditions (Figure S4E), compatible with our
in vivo results showing no influence on proliferation, migration
and cell fate after viral vector-mediated knockdown or overex-
pression in vivo. Taken together, these data identify CryaA as
a key regulator of the apoptotic pathway in neurons.
Pax6 Homeodomain Controls CryaA Expression
Downregulation of CryaA expression in dopaminergic PGNs after
loss of Pax6 suggests that Pax6 may directly control CryaA
expression. Pax6 regulates target gene expression by three
DNA-binding domains, the paired domain (PD) with the PAI andNeuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc. 687
Figure 5. Pax6 Homeodomain Activates
CryaA Expression
(A) Scheme depicting different forms of the Pax6
transcription factor (B). The canonical, 5a, and
PD-less Pax6 forms activate reporter gene
expression driven by the 2.1 kb CryaA promoter
(Yang et al., 2006), while introduction of a point
mutation interfering with the homeodomain DNA-
binding in the PD-less form (blue ring in A)
abolishes the reporter activation (five experiments)
in the Pax6-expressing P19 cell line.
(C) The relative abundance of different Pax6 forms
measured at RNA (qRT-PCR) and protein (western
blot) level in the adult OB and SEZ.
(D) Western blot for Pax6 depicting enrichment of
PDless Pax6 form (arrow) in the OB compared to
the SEZ lysates. Note that both SEZ and OB
contain canonical Pax6 and Pax65a (50–55 kD
bands).
(E) HEK293T cells do not express any Pax6 forms.
Western blot for Pax6 in nontransfected (right line)
and HEK293T cells transfected with constructs
expressing Pax6 (left line) or Pax65a (middle line)
using AB2237 antibody that recognize all Pax6
forms because of C-terminal binding.
(F) InHEK293T cells lacking endogenousPax6, co-
expression of canonical andPD-less forms of Pax6
is necessary to activate 2.1 kb CryaA promoter
(Yang et al., 2006) (red bar), while Pax6, Pax65a,
and PD-less alone do not activate the reporter
construct. Note that the point mutation affecting
DNA binding capacity of HD abolished CryaA
promoter activation.
(G) PD-less interacts with canonical Pax6 in the
OB. Western blot for all Pax6 forms (rabbit anti-
Pax6 antibody [see Figure S4]) in immunoprecipi-
tates of canonical Pax6 (immunoprecipitated with
the N-terminal Pax6 antibody [see Figure S4])
from total lysates of the adult OB. No signal for
Pax6 forms was detected in the wash fraction or
immunoprecipitates using IgG control, whereas
signals for both canonical (black arrow) and PD-
less Pax6 (red arrow) forms were detected after
both EtBr and benzonase treatment indicated
direct protein-protein interaction in the adult OB
between full length Pax6 and PD-less.
(H and I) Histograms depicting Pax6 (H) and H3 K9ac (I) distribution at the mouse aA-crystallin gene locus in OB chromatin. The numbers on x axis represent the
primer position in CryaA locus (Yang et al., 2006). The red line indicatesmedian background signal averaged through theCryaA locus. The relative enrichment (RE)
unit represents 10% of the input.
*p < 0.05; ***p < 0.001 and brackets in (B), (C), (F), (H), and (I) are SEM. See also Figure S5.
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Figure 5A). Alternative splicing (Epstein et al., 1994) or different
transcription initiation (Glaser et al., 1992) generate mainly three
Pax6 forms, the canonical Pax6 containing all three DNA-binding
motifs, the Pax6(5a) form in which binding of the PAI domain to
DNA is abolished and the PDless form that lacks the entire paired
domain (PD-less) and can bind DNA only via its homeodomain
(Figure 5A; see also Haubst et al., 2004). To test whether any of
these Pax6 proteins would regulate CryaA we examined
transcriptional activation of the 2.1 kb CryaA promoter (Yang
et al., 2006) in luciferase assays performed in N2A and P19 cells
(Figures 5A and 5B). Consistent with previous data obtained
with lens cells (Yang et al., 2006), transduction of Pax6 forms
containing the PD and HD (canonical and 5a) led to a significant688 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.increase in CryaA promoter mediated luciferase expression
(Figure 5B). In contrast to the data obtained with lens cells, we
also observed activation by the PDless protein (Figures 5A and
5B). DNAbinding of this HD is essential for activation of theCryaA
promoter as a point mutation abolishing DNA binding of the HD
(Pax64Neu) (Favor et al., 2001) also abolished the activation of
this promoter (Figure 5B). Taken together, these data suggest
that Pax6 directly regulates CryaA expression by DNA binding
of the HD.
We next examined the expression of the different forms of
Pax6 in the OB in vivo and found expression of the PDless
form, which was virtually absent in the subependymal zone,
where adult neural progenitor cells and neuroblasts express
Pax6 (Brill et al., 2008; Hack et al., 2005). In contrast, canonical
Neuron
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S6J). These data suggest the intriguing concept that mature
neurons expressing Pax6 in the OB specifically upregulate the
PD-less form of Pax6.
Given the coexistence of canonical and PD-less forms of Pax6
in vivo (Figures 5C and 5D), we further tested the influence of
endogenous Pax6 expressed in P19 cells (Figure S5) by using
a cell line lacking endogenous Pax6 expression, HEK293T.
When we transduced these cells with the canonical or PD-less
form of Pax6, no activation of the CryaA promoter was observed
(Figure 5F) in striking contrast to the results obtained in the cell
line with endogenous Pax6 levels (Figure 5B). However, cotrans-
duction of the canonical and PD-less form of Pax6 resulted in
very strong transcriptional activation of the CryaA promoter
(Figure 5F), demonstrating the necessity of these forms to
interact. This potent activation was fully abolished by cotrans-
duction of the canonical Pax6 with the PD-less homeodomain
mutant (PD-less Pax64Neu) (Figure 5F). These results show that
CryaA transcription depends exclusively on the DNA binding
activity of the Pax6 HD of the PDless protein, since it cannot
be compensated by the nonmutant HD of the canonical Pax6,
and requires interaction of the PD-less form with the canonical
form of Pax6.
To examine whether the requirement for both the full length
and PD-less form of Pax6 depends on a physical interaction of
the two proteins, we performed coimmunoprecipitation experi-
ments in protein extracts from the adult OB. To do so we took
advantage of an N-terminal Pax6 antibody that does not recog-
nize the PD-less protein lacking the N terminus (Figures S4F and
S4G). Precipitation with this antibody should therefore precipi-
tate only Pax6 forms containing a PD (either canonical or 5a).
The immunoprecipitates were then probed with a C-terminal
Pax6 antibody recognizing all Pax6 forms (Figure S4F). We
observed the PDless protein in Western blots (red arrowhead
in Figure 5G). As these experiments were performed after
treatment with ethidium bromide or benzonase blocking protein
DNA interactions, the data suggest a direct protein-protein
interaction between the full length and PDless Pax6 proteins
(Figure 5G). Taken together with the data obtained in the
luciferase experiments, we conclude that CryaA expression is
regulated by HD-mediated DNA binding of a complex consisting
of the Pax6 full length and PD-less protein. To demonstrate that
Pax6 interacts with the CryaA locus in vivo, we isolated
chromatin from OBs of 3-month-old animals and performed
a series of qChIP analyses (Figure 5H). The enrichment of Pax6
was found in the CryaA promoter region (regions 500 and
250 bp; Figure 3H). In addition, the 500 bp promoter region
showed increased signals corresponding to H3 K9 acetylated
histones (Figure 3I), a mark localized to the 50 regions of tran-
scriptionally active genes (Liang et al., 2004). Taken together,
these data suggest that Pax6 directly regulates CryaA expres-
sion through association with the upstream promoter regions
in chromatin of OB cells.
Paired-Type Homeodomain Dysfunction Impairs
Survival of Dopaminergic PGNs
The above experiments suggested a critical role of the HD in
regulating CryaA expression and hence dopaminergic PGNsurvival.Wetestedthis invivo inamouse lineharboringapointmu-
tation in the Pax6 HD abolishing DNA binding, the Pax6132-14Neu
(further named Pax614Neu) mice (Favor et al., 2008). In contrast
tomostPax6mutants (Favoretal., 2008;Grawetal., 2005;Haubst
et al., 2004), Pax614Neu is not homozygous lethal. Consistent with
normal forebrain development in Pax6 mutants with a defective
HD (Haubstet al., 2004), adultmicehomozygous for thePax614Neu
allele also do not show gross morphological changes in the
forebrain (Figures S6A–S6C). This allowed us to further study
both neurogenesis and survival of dopaminergic neurons in these
animals. First, we examined the presence and number of adult
neural stem cells in the subependymal zone of Pax614Neu mice
by the neurosphere assay. The number of neurospheres
generated, their size and their self-renewing capacity did not
differ in Pax614Neu mice compared to their WT siblings (Figures
S6D–S6F). Moreover, neurospheres from the Pax14Neu mutants
were tripotent and not different from WT cells in regard to the
proportion of neurons, oligodendrocytes and astrocytes
generated 7 days after withdrawal of growth factors (Figures
S6G–S6H).
As the full length form of Pax6 was previously implicated in
adult neurogenesis (Hack et al., 2005; Kohwi et al., 2005), we
examined neuroblasts in sections by immunostaining for double-
cortin (DCX) and by FACS using live staining for PSA-NCAM.
Neuroblasts were present in equal numbers and locations in
the Pax614Neu/14Neu mutants and their heterozygote or WT litter-
mates in both read-outs (Figure S6I and data not shown). As the
proportion of PSA-NCAM-positive was quantified in the OB, we
can further conclude that an equal number of young neurons
arrive to the OB of Pax614Neu/14Neu animals as in their WT siblings
(Figure S6I), demonstrating that neurogenesis and neuronal
migration are normal in these mutant mice. This is in full agree-
ment with previous work demonstrating that the DNA-binding
mutations of the HD of Pax6 do not affect proliferation,
neurogenesis, and neuronal migration during development
(Haubst et al., 2004).
However, when we examined the composition of PGNs in the
glomerular layer of 3.5-month-old Pax614Neu/14Neu mice, we
observed a significant reduction of DAT+ PGNs to 20% of that
of control mice (Figures 6B and 6G). All other PGN subtypes
were unaffected (Figures 6C–6G). To examine whether this
was due to a failure of DAT+ neurons to be generated or to
survive, we applied BrdU to label recently generated dopami-
nergic neurons. The recently (4–6 weeks before) generated
DAT+ neurons comprise only 10% ± 3% of all DAT+ PGNs in
control mice (3 animals examined and at least 500 cells counted
per genotype). In contrast, the vast majority of the few DAT+
neurons present in the OB of homozygous Pax614Neu mice
were all recently generated (80% ± 5% BrdU+), suggesting
that in Pax614Neu mice DAT+ neurons are generated but
quickly lost. Taken together, these data strongly suggest that
survival of dopaminergic PGNs is severely compromised in
Pax614Neu/14Neu mice.
Consistent with the evidence presented above that the HD of
Pax6 is essential to regulate CryaA, we detected a significant
reduction in the density of CryaA+ cells in the Pax614Neu/14Neu
selectively in the glomerular layer (Figure 6H) which was due
to a strong reduction in the number of DAT and CryaANeuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc. 689
Figure 6. Pax6 Homeodomain Is Necessary for the Maintenance of Dopaminergic OB Interneurons
(A, B, and G) Mature dopaminergic neurons immunoreactive for DAT (green) are significantly decreased in the Pax614Neu mutant (six animals) deficient for
homeodomain function (A and G) compared to theWT (four animals) (B andG) or heterozygous (six animals) siblings (G). The proportion of calretinin and calbindin
positive cells did not significantly differ between the mutant and heterozygote or WT animals (G).
(C–F) Micrographs depicting calretinin (C and D) and calbindin (E and F) immunoreactive populations in the OB of Pax614Neu/14Neu mice (D and F) and their WT
siblings (C and E). Note the comparable number of calretinin+ or calbindin+ PGN subtypes in mutant andWT (G). All images are maximum intensity projections of
30 mm optical z stacks.
(H) The density of CryaA-positive cells is significantly reduced in the GL of Pax614Neu mutants compared to their WT or heterozygous siblings but did not differ in
any other OB layer analyzed (three animals analyzed per genotype).
(I) Histogram depicting the reduction in CryaA-positive dopaminergic periglomerular neurons in Pax614Neu mutants compared to their WT or heterozygous
siblings (three animals analyzed per genotype).
Abbreviations: DAT, dopamine transporter; GL, glomerular layer; GCL, granular cell layer; ***p < 0.001 and *p < 0. 05; brackets in (G), (H), and (I) are SEM. Scale
bars 50 mm. See also Figure S6.
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analyzed) compared to their WT or heterozygous siblings. Thus,
these data are consistent with the concept that the DNA-binding
mutation in the HD of Pax614Neu causes a downregulation of
CryaA in dopaminergic PGNs which results in death of this
population. Importantly, no changes in mRNA of either PD or
HD containing forms of Pax6 as measured by qPCR were
detectable in E14 cortices and adult OBs of Pax614Neu/14Neu
mutants and their age-matched Pax614Neu/+ siblings (Figure S6K
and data not shown), supporting the concept that the loss
of DAT+ PGNs via loss of CryaA is indeed due to the point muta-
tion in the HD rather than alterations in the overall expression
levels of Pax6 that are observed in the full Pax6 mutants and can
cause cell death (Holm et al., 2007; Tuoc and Stoykova, 2008).
DISCUSSION
Here, we revealed a function of Pax6 in regulating the survival of
specific neuron subtypes in the adult brain. We demonstrated
that this function is achieved by utilizing a different DNA-binding690 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.domain as used in the developmental functions of Pax6 and is
exerted by the regulation of CryaA. CryaA is required to prevent
the activation of the caspase cascade and thereby inhibits
progression of the dopaminergic OB interneurons to PCD in
the adult mouse brain. These results thereby demonstrate
a pathway to regulate neuron survival in the adult brain in
a subtype-specific manner.
Neuron Survival in the Adult Brain
During development, especially of the peripheral nervous
system, PCD is part of the program sculpturing neuron numbers
and thereby neuronal connectivity (Dicou and Perez-Polo, 2009).
PCD is actively inhibited by external survival cues (Chang and
Johnson, 2002) or cell intrinsic mechanisms (Hatzold and
Conradt, 2008) regulating different signaling cascades to inhibit
the activation of procaspase-3 and thereby promoting the
survival of the correct cell types in appropriate numbers (for
review see Conradt (2009).
In contrast, little is known about the regulation of neuronal
survival in the normal, uninjured adult brain. The number of
Neuron
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no neuronal cell death occurs. However, in the regions of the
adult brain where neurogenesis continues also PCD continues
and only about half of all newly arriving neuroblasts survive
(Petreanu and Alvarez-Buylla, 2002). The turnover mode of
neurons with replacement of about 10% by newly arriving
neurons has been most clearly established in the dentate gyrus
(Lagace et al., 2007; Ninkovic et al., 2007) and implies a rather
specific regulation of neuronal survival. Notably, the mode of
neuron incorporation in the glomerular layer (GL) is very different.
Long-term fatemapping of adult generated neurons has revealed
a constant increase in their proportion in the GL (Ninkovic et al.,
2007), suggesting the addition of new neurons to this network
rather than a replacement of preexisting neurons.
Our data now demonstrate mature neurons in the GL require
the direct transcriptional orchestration of a survival pathway.
We showed that CryaA is expressed in the brain in a highly
region-specific manner and acts as an essential survival factor
in dopaminergic OB interneurons in the adult mouse brain
(Figure 3). CryaA prevents procaspase-3 activation possibly by
interaction with Bax and Bcl-Xl as demonstrated in the lens
(Mao et al., 2004) or by physical interaction and inhibition of its
autocatalytic activation (Kamradt et al., 2001). Moreover, crystal-
lins, as molecular chaperons, interact with the cytoskeleton (Bai
et al., 2007) and prevent the deposition of protein aggregates
(Bai et al., 2007; Narayanan et al., 2006; Rekas et al., 2004)
thereby promoting cell survival (Andley, 2007) in a caspase-inde-
pendent manner. However, our data are not consistent with the
lattermechanisms ofCryaA function since cell death by aggrega-
tion of proteins would be expected to occur at a slower pace than
observed after shRNA-mediated knockdown and the loss of
Pax6 and CryaA in the Pax6 mutant OBs. Moreover, our in vitro
experiments also support a direct role of CryaA in the regulation
of cell survival by influencing procaspase-3 activation. It has
beenpreviously shown that deletion ofCryaA leads to adecrease
in Bad S136 phosphorylation, a potent signal for apoptosis (Xi
et al., 2008). In addition, CryaA also interacts with p53 and hence
its loss may affect cell death at various levels (Andley, 2007).
Oneof themost important aspects of thiswork is the specificity
of this pathway affecting exclusively dopaminergic OB interneu-
rons. Knockdown of CryaA in other adult generated neurons did
not affect their survival. This is particularly relevant in regard to the
alterations of dopaminergic OB interneuron numbers which have
been observed in Parkinson’s disease patients (Hirsch et al.,
1987; Shih et al., 2007; Sulzer, 2007). Interestingly, P19 cells
that also depend on CryaA for suppression of caspase-3-depen-
dent cell death are also both GABAergic and dopaminergic
(Staines et al., 1994) and express Pax6 as well as CryaA. It may
thusbe thatCryaA is involved in a specific survival pathwayactive
in OB dopaminergic neurons. While we did not observe CryaA
expression in midbrain dopaminergic neurons, different
members of the crystallin family are expressed in different brain
regions and may be implicated in regulating neuronal
survival (Ganguly et al., 2008; Magabo et al., 2000; Renkawek
et al., 1992).Other homeobox transcription factors could regulate
crystallins in other neuronal subtypes, such that this survival
pathway may play a general role in specific neurons of the adult
brain. The finding that neuronal survival in a healthy adult brainis regulated in a subtype-specific manner is therefore highly
relevant to the subtype-specific vulnerability of neurons in
many neurodegenerative diseases.Pax6 Exerts Different Functions via Distinct
DNA-Binding Domains
The survival pathway in dopaminergic OB neurons is mediated
by the same TF specifying these neurons, but utilizes a different
DNA-binding domain, namely the homeodomain. Interestingly,
the regulation of CryaA via the HD in the brain is not semidomi-
nant as PD-regulated effects of proliferation, neurogenesis,
and patterning during development (Ellison-Wright et al., 2004;
Estivill-Torrus et al., 2002; Go¨tz et al., 1998; Heins et al., 2002;
Kroll and O’Leary, 2005; Stoykova et al., 2000; Toresson et al.,
2000; Yun et al., 2001). This is rather different in eye develop-
ment, where mutations of the HD exhibit strong and early
phenotypes (Favor et al., 2001, 2008). Notably, the regulation
of crystallins is mediated by the PD in the eye and in lens cells
(Chauhan et al., 2002; Cvekl and Duncan, 2007; Cvekl et al.,
1994; Wolf et al., 2009), while we show here that it requires the
interaction with a full-length and a PDless Pax6 to mediate
HD-dependent target regulation.
Lack of Pax6 function can also result in cell death in the devel-
oping forebrain (Nikoletopoulouet al., 2007). Interestingly, this cell
death is mediated by p75 and occurs as a consequence of
misspecification as the misspecified Pax6 mutant GABAergic
neurons survive well in other brain regions where GABAergic
neurons are normally generated (Nikoletopoulou et al., 2007). In
thenormal casePax6-positiveprogenitorsgive rise toglutamater-
gic neurons (Kroll and O’Leary, 2005; Nikoletopoulou et al., 2007;
Stoykova et al., 2000). In the absence of Pax6, upregulation of the
transcription factors Gsh2,Mash1, andDlx2 occurs and results in
the generation of GABAergic neurons (Kroll and O’Leary, 2005;
SchuurmansandGuillemot, 2002;Stoykovaetal., 2000;Toresson
et al., 2000).When the transientwaveof early cell death is rescued
by p75 depletion, the misspecified GABAergic neurons survive
(Nikoletopoulou et al., 2007). Conversely, rescue of Pax6-defi-
cientdopaminergicOBneurons resulted in the survival of dopami-
nergic and not other misspecified neuronal subtype. Pax6
expression is transient in the stem and progenitor cells of the
developingcerebral cortexand it doesnotcontinue in thedifferen-
tiating glutamatergic neurons in this region (Go¨tz et al., 1998). This
further highlights that the cell death ofmisspecified neurons in the
developing cortex is not a direct cause of absence of Pax6
function but depends on the local environment and neuronal
misspecification. Conversely, Pax6 exerts a primary role in the
regulation of neuronal survival in adult neurons, where it is contin-
uously expressed, by direct regulation of the survival component
CryaA that inhibits the apoptosis pathway. Taken together, Pax6
changes its role from PD-mediated transcriptional regulation
specifying fate in progenitor cells to HD-mediated transcriptional
regulation of cell survival in mature neurons.EXPERIMENTAL PROCEDURES
Animals
DAT::Cre (Zhuang et al., 2005), Pax6fl (Ashery-Padan et al., 2000), and Z/EG
(Novak et al., 2000) were maintained on C57BL6/J background. AnimalsNeuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc. 691
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procedures were performed in accordance with German and European Union
guidelines. Stereotactic injections of retroviruses into the brain of adult mice
were approved by the Government of Upper Bavaria in license number 211-
2531-23/04 and 55.2-1-54-2531-144/07.
Histology and Immunostaining
Immunostainings and analyses were performed as previously described (Brill
et al., 2008). Antibodies used: anti-calbindin (Swant, mouse IgG, 1: 200), anti-
calretinin (Swant, mouse IgG, 1: 200), anti-Cre (Chemicon, rabbit, 1:200),
anti-crystallinaA (Abcam, rabbit, 1:1000), anti-DAT (Abcam, rat, 1:500), anti-
dsRed (Chemicon, rabbit, 1:1000), anti-doublecortin (DCX, Chemicon, Guinea
pig, 1:1000), anti-GFAP (SIGMA, IgG1, 1:100), anti-GFP (Chemicon, rabbit,
1:5000 or Aves, chicken 1:500), anti-NeuN (Chemicon, IgG1, 1:75), anti-Pax6
(Chemicon, rabbit, 1:700), anti-TH (Chemicon, chick, 1:200), anti-BrdU (rat,
1:200, Abcam) .
In Situ Hybridization
Digoxigenin-labeled RNA probes for CryaA, CryaB, CrybB2, and Cryg (kindly
provided by J. Graw) were made and used as described previously (Brill et al.,
2008).
Western Blot
Specific brain areas were dissected and lysed in RIPA buffer containing
protease and phosphatase inhibitors (Roche). Ten micrograms of total
proteins were separated by 10% SDS-PAGE and transferred to PVDF
membranes (Bio-Rad). Membranes were incubated with primary antibodies
followed by horseradish peroxidase labeled secondary antibodies (1:25 000;
Amersham). These were detected by ECL Western Blotting Detection (Chem-
icon). The abundance of the band was quantified using ImageJ software after
background correction.
Immunoprecipitations
Nuclear extracts were prepared from freshly dissected OBs and dialyzed to
100mMKCl as described previously (Dignam et al., 1983). For the immunopre-
cipitation, 10 mg of anti-Pax6 antibody (Hybridoma Developmental Bank) was
used for 300 ml of OB nuclear extract
FACS Analysis for Cell Death and Neuroblasts
Olfactory bulbs were dissected and dissociated to single-cell suspension as
previously described (Brill et al., 2008). Single-cell suspensions were assessed
for cell death using PI/annexinV kit (eBioscience) and FACS analysis according
to the manufacturers’ recommendations. To assess number of neuroblasts,
cells were labeled with mouse anti/PSA-NCAM antibody (Chemicon, 1: 500)
for 15 min on ice, followed with Cy-5 conjugated secondary antibody and
FACS analyses.
Luciferase Assay
Expression plasmids for luciferase reporter assays were constructed using
full-length cDNA of mouse Sox2, Pax6, Pax6(5a), and PDless cloned into the
pMXIG vector. The empty vector was used as control. The 2.1 kb CryaA
promoter was cloned into the pGL3 vector (Promega). The CryaA promoter
was PCR amplified from genomic DNA using the following primers:
50-TTTATGTATATGAGTACGCTGTTGC and 50-TCTATTTGGTGATGCAGGGA.
We used mouse neuroblastoma (Neuro-2A) and mouse embryonic carcinoma
P19 cells (0.5 3 105 cells/ cm2) and assays we performed according to the
manufacturer’s instructions (Promega).
Viral Constructs, Virus Production, and Stereotactic Injections
Full-length cDNA of mouse CryaA was cloned into CAG-RFP retroviral vector
(cytomegalovirus immediate-early enhancer-chicken b-actin hybrid-red
fluorescent protein). An empty CAG-dsRed vector was used as a control.
Retrovirus was produced in a packaging cell line (GPG-293) after transient
transfection with the retroviral expression plasmid. Estimation of the viral titer
was performed as described (Hack et al., 2005) and titered to 5 3 107
colony-forming units (cfu) ml1. For all experiments, 10-week-old males were
stereotactically injected with 1 ml of either CAG-DsRed, CAG-CryaA-DsRed,692 Neuron 68, 682–694, November 18, 2010 ª2010 Elsevier Inc.or shRNA lentiviruses into the left and the right RMS (coordinates relative to
the bregma were (in mm): 2.8 anterior/posterior, 0.75 medial/lateral, and
1.9 dorsal/ventral from the dura).
Short-Hairpin RNAs
The short-hairpin RNAs (shRNAs) were designed using BLOCK-iT RNAi
Designer (Invitrogen) against the full-length cDNA of CryaA and contain sense,
four nucleotides CGAA as the loop, antisense sequences and two adapters
for theBglII andHindIII sites.Thesynthesizeddouble-strandedDNAnucleotides
were annealed and ligated into pLVTH plasmids (Wiznerowicz and Trono,
2003) after the H1 promoter. Oligonucleotides designed for CryaA were
CryaA_shRNA5: GACTGTTCGACCAGTTCTTCG (21 bp) and CryaA_shRNA6:
GTCACCATTCAGCATCCTTGG (21 bp) and nonspecific shRNA: GGTTTGGCA
TATAATCTATCG (21 bp). P19 cells were transiently transfectedwith the shRNA
encoding plasmids using Lipofectamine2000 (Invitrogen) according to the
manufacturers’ specifications and assayed for either cell death or immunocyto-
chemistry as described above.
Chromatin Immunoprecipitation (ChIP) Assays
The qChIP experiments were performed as described (Cuddapah et al., 2009;
Lee et al., 2006) with minor modifications. The detailed protocol is available in
supplemental material. We used rabbit anti-Pax6 (Millipore/Chemicon, cat #
ab2237) or H3K9ac polyclonal antibodies (Abcam, cat #ab4441) for IP.
Quantitative Analysis
Quantifications (proportions of reporter-positive cells among particular cell
types) were done using ImageJ software to analyze confocal Z stacks. At least
10 (per animal) corresponding sections were sampled and analyzed at
different mediolateral positions and the number of animals is indicated for
every experiment. All results are presented as mean and standard error of
the mean. Statistical analysis was performed in Microcal Origin 7.5 using
ANOVA and Mann-Whitney U test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.neuron.2010.09.030.
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